Location History:
- Bloomfield, NJ (US) (2014 - 2023)
- Newton, MA (US) (2018 - 2023)
Company Filing History:
7 out of 4,948 
2 out of 68 
1 out of 2,078 
Years Active: 2014-2023
Title: Kathryn Elizabeth Packman: Innovator in Cancer Treatment
Introduction
Kathryn Elizabeth Packman is a prominent inventor based in Newton, MA (US). She has made significant contributions to the field of cancer treatment, holding a total of 10 patents. Her innovative approaches focus on maximizing anti-tumor activity while minimizing toxicity levels.
Latest Patents
Among her latest patents is a method for administration that provides a new dosage regimen for Compound A. This regimen is designed to maximize anti-tumor activity while maintaining acceptable toxicity levels. Another notable patent involves methods of treating cancer using PRMT5 inhibitors. This patent outlines a comprehensive approach for treating patients diagnosed with cancer by administering a therapeutically effective amount of a PRMT5 inhibitor. The methods include specific dosing schedules that ensure optimal treatment outcomes.
Career Highlights
Throughout her career, Kathryn has worked with notable companies such as Hoffmann-La Roche Inc. and Roche Glycart AG. Her experience in these organizations has allowed her to develop and refine her innovative ideas in cancer treatment.
Collaborations
Kathryn has collaborated with esteemed colleagues, including Brian Higgins and Kenneth Kolinsky. These partnerships have further enhanced her research and development efforts in the field of oncology.
Conclusion
Kathryn Elizabeth Packman is a trailblazer in the realm of cancer treatment innovations. Her patents and collaborative efforts reflect her commitment to improving patient outcomes through advanced therapeutic methods.